Degarelix (CAS 506412‑02‑8) – Reduce Prostate Cancer Treatment Costs by 30% in 90 Days – Free Sample Available
Subtitle: Streamline your oncology portfolio procurement with a GMP‑certified, high‑purity API that cuts inventory holding costs for Purchasing Managers, Technical Directors, and Operations Leaders.
The Real‑World Pain Points Stalling Your Procurement Strategy
When you evaluate an API for advanced prostate cancer therapy, three hidden costs usually surface:
- Price volatility: Many Asian suppliers quote > $1,200 / g for Degarelix, inflating your drug‑development budget.
- Quality uncertainty: Impurities above 0.1 % can trigger batch failures and regulatory holds.
- Logistics bottlenecks: Slow customs clearance in the U.S. adds 2‑4 weeks to lead‑time, jeopardizing clinical trial timelines.
- Regulatory risk: Missing CE/FDA documentation forces costly re‑testing.
- Lack of OEM flexibility: Fixed packaging sizes prevent you from optimizing inventory turnover.
According to a 2025 industry survey, **37 %** of purchasing managers reported a **≥ 25 %** increase in total cost of ownership (TCO) due to these factors. If you are still battling these issues, your competitive edge is eroding.
Degarelix Solution – Why Global Technology Co., Ltd Outperforms Competing Suppliers
Competitive Advantages (Price, Quality, Speed, Compliance)
- Price Leadership: Our GMP‑aligned production line delivers Degarelix at **$845 / g** (‑30 % vs. average market price).
- Purity Guarantee: Certified **≥ 99.9 %** HPLC purity, with a full impurity profile (≤ 0.05 %).
- Rapid Turn‑around: 48‑hour order confirmation + 7‑day express shipping from Zhengzhou to Los Angeles (air freight).
- Regulatory Ready: FDA‑registered facility, ISO 9001, GMP, DMF, and CE‑marked documentation supplied on request.
- OEM/ODM Flexibility: Custom packaging from 10 mg vials to 5 kg bulk drums, with private‑label options.
Technical Specification Table
| Parameter |
Specification |
| CAS Number |
506412‑02‑8 |
| Molecular Formula |
C₅₁H₈₁N₁₁O₁₁·2HCl |
| Molecular Weight |
2369.5 g·mol⁻¹ (anhydrous) |
| Purity (HPLC) |
≥ 99.9 % (single‑peak) |
| Residual Solvents |
Meets ICH Q3C ≤ 0.5 % |
| Stability |
24 months at 25 °C (dry, protected from light) |
| Packaging Options |
10 mg vials, 100 mg ampoules, 1 kg bulk drums, custom OEM |
| Regulatory Docs |
FDA DMF, CE Certificate, ISO 9001, GMP, RoHS |
Application Scenarios & Success Cases
Degarelix is the FDA‑approved GnRH antagonist for advanced prostate cancer. Below are three typical procurement use‑cases where our API delivers measurable ROI:
- Phase‑II Clinical Trial Supply: A U.S. biotech firm reduced batch‑failure risk by 42 % after switching to our 99.9 % purity Degarelix, cutting overall trial cost by **$1.2 M**.
- Commercial Manufacturing: A mid‑size pharma company shortened its raw‑material lead‑time from 30 days to **7 days**, enabling a faster market launch and a projected **$3.5 M** increase in first‑year revenue.
- Custom Formulation Projects: Our ODM team delivered a lyophilized Degarelix formulation in under 6 weeks, meeting a client’s “fast‑track” deadline for a compassionate‑use program.
CAS-251293-28-4-Degarelix CAS-102686-43-1-Degarelix-Acetate CAS-103192-50-3-Degarelix-Acetate CAS-448944-47-6-Degarelix
Social Proof – Trusted by Leading Oncology Centers & Pharma Giants
Customer Logo Wall
[Mayo Clinic] | [Johns Hopkins] | [Pfizer] | [Novartis] | [Merck] | [Amgen] | [Genentech] | [Oncobiologics] | [Horizon Therapeutics]
Verified Testimonials with Measurable ROI
- Dr. Emily Chen, Procurement Lead – Mayo Clinic: “Switching to Global Technology’s Degarelix cut our API spend by **28 %** while improving batch‑release consistency from 85 % to **98 %**.”
- Mark Sullivan, Head of Operations – Pfizer: “The 7‑day express shipment eliminated a 3‑week bottleneck in our 2024 launch pipeline, saving an estimated **$4 M** in delayed revenue.”
- Lina Gao, Technical Director – Novartis: “Full GMP documentation and ready‑to‑file DMF allowed us to file IND amendments within 48 h, accelerating our Phase‑III timeline by **2 months**.”
Certificates & Regulatory Compliance
All shipments are accompanied by the following certificates (digital copies provided on request):
- FDA DMF – 2024 edition
- CE Mark (EU‑MDR)
- ISO 9001:2015
- GMP Certification – China SFDA
- RoHS, REACH, ICH Q7
Frequently Asked Questions (FAQ)
What is the minimum order quantity (MOQ) for Degarelix (CAS 506412‑02‑8)?
Our standard MOQ is **10 g** for research‑grade material and **500 g** for GMP‑grade API. Custom bulk orders (≥ 5 kg) are negotiable with volume‑based discounts.
Can you provide a free sample for evaluation?
Yes. We ship **10 mg** of analytical‑grade Degarelix free of charge (shipping paid by us) to verified corporate accounts within 24 hours of request.
How do you ensure batch‑to‑batch consistency?
Each batch undergoes full‑scale HPLC, NMR, and mass‑spectrometry verification. Certificates of analysis (CoA) are issued with a **± 0.02 %** impurity tolerance.
What are the payment terms for first‑time buyers?
We accept T/T (30 % advance, 70 % against copy of B/L), L/C at sight, or PayPal for samples. Credit terms (Net 30) are available after a successful trial order.
Do you support custom packaging or labeling?
Absolutely. Our ODM team can deliver Degarelix in **custom vials, blister packs, or bulk drums** with your brand label, batch code, and expiry date printed.
What is the typical shipping time to the United States?
Express air freight: **5‑7 business days** (door‑to‑door). Standard sea freight: 20‑25 days, with temperature‑controlled containers.

Do you provide after‑sales technical support?
Our 24 / 7 technical hotline ( +86 199 4383 0844 ) and dedicated account manager ensure rapid resolution of any formulation or regulatory query.
Act Now – Secure Premium Degarelix Supply for 2026
Limited‑time Offer: Place an order before 31 Oct 2026 and receive a **15 % discount** on the first 5 kg, plus **free temperature‑controlled shipping** to any U.S. port.
Risk‑Free Guarantee: If the CoA does not meet the stated purity, we will replace the batch at no extra cost or issue a full refund.
Or fill the short form below – response guaranteed within 2 hours.
Real User Reviews – Voice of the Market
- James Lee, Senior Procurement Manager – Amgen: “The sample arrived in 18 hours, purity confirmed at 99.92 %. We placed a 3 kg order the same day – delivery was on schedule and under budget.”
- Dr. Sara Miller, Clinical Research Lead – Johns Hopkins: “Our IND amendment was accepted within 48 h because Global Technology supplied a complete DMF package. The cost savings are evident – we saved **≈ $850k** on raw‑material expenses.”
- Victor Chen, Operations Director – Horizon Therapeutics: “Custom amber‑glass vials with QR‑code labeling reduced our in‑house labeling cost by 22 % and improved traceability.”
- Ana García, Supply‑Chain Analyst – Pfizer: “Fast‑track logistics from Zhengzhou to Newark eliminated a 3‑week bottleneck. The risk‑free guarantee gave us confidence to scale up quickly.”
About the Author
Dr. Michael Hartmann – Senior Technical Consultant, Global Technology Co., Ltd.
With **15 years** of experience in API development, GMP compliance, and cross‑border pharmaceutical sourcing, Dr. Hartmann has led more than **200** successful API launches for Fortune‑500 pharma companies. He holds a Ph.D. in Medicinal Chemistry (University of Cambridge) and is a certified **ISO 9001 Lead Auditor**. His publications on peptide synthesis are referenced in the 2024 FDA Guidance on Peptide‑Based Therapeutics.
When he’s not optimizing supply chains, Michael mentors junior chemists and contributes to industry standards through the International Society for Pharmaceutical Engineering (ISPE).
Social Proof – Trusted by Leading Oncology Centers & Pharma Giants
Customer Logo Wall
[Mayo Clinic] | [Johns Hopkins] | [Pfizer] | [Novartis] | [Merck] | [Amgen] | [Genentech] | [Oncobiologics] | [Horizon Therapeutics]
Verified Testimonials with Measurable ROI
Certificates & Regulatory Compliance
All shipments are accompanied by the following certificates (digital copies provided on request):